-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Ovid Therapeutics Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q4 2024.
- Ovid Therapeutics Inc. Operating Margin for the quarter ending December 31, 2024 was -10.9K %, a 27.7% increase year-over-year.
- Ovid Therapeutics Inc. annual Operating Margin for 2024 was -10.9K %, a 27.7% increase from 2023.
- Ovid Therapeutics Inc. annual Operating Margin for 2023 was -15.1K %, a 309% decline from 2022.
- Ovid Therapeutics Inc. annual Operating Margin for 2022 was -3.7K %, a 6301% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)